C-[5-(4-Nitro-phenyl)-[1,3,4]oxadiazol-2-yl]-methylamine; hydrochloride, 95.0%, 1g

Methyl (1S,3S,4R)-2-[(1R)-1-phenylethyl]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate, 95%, 500mg

1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile, 95.0%, 250mg

Fmoc-Aoa, 98.0%, 1g

Chromatographie-Papier, Typ MN 261, Schichtdicke 0,18 mm, 58x60 cm, 100 Stück

5-Iodo-2-methoxypyridine>98.0%(GC)5g

1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazole-4-carbaldehyde, 98%, 50g

(3S,4S)-3-(BOC-AMINO)-4-FLUORO-PYRROLIDINE, 95.0%, 250mg

N-Cbz-6-Bromo-hexylamine, 97.0%, 5g

1-Chloro-4-[(2-chloroethyl)sulfonyl]benzene, 97.0%, 1g

2-(6-Methylpyridin-3-yl)propan-2-ol, 97%, 100mg

Tert-butyl 4-(4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 95%, 100mg

tert-Butyl 4-oxopentanoate, 98%, 1g